CD8A and neoplasm: Two studies have reported that the relative fraction of PD-1hiCD8+ T cells in CD8+ cells, rather than the absolute fraction in total tumor tissue as estimated by our signature score, was negatively associated with ICI therapy outcomes (21, 52).